Author

A. Szlachetka

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Pharmacology & Toxicology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:human· 1 Organism:multiple species· 1 Assay:proteomics· 1

Frequent Co-Authors

A. N. Bade· 1 shared B. J. Edagwa· 1 shared B. L. Dyavar Shetty· 1 shared B. Sillman· 1 shared D. Kumar· 1 shared H. E. Gendelman· 1 shared J. M. McMillan· 1 shared N. A. Smith· 1 shared

Activity by Year

2021-2021 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperPharmacology & Toxicology

A. N. Bade

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Lipophilic Nanocrystal Prodrug-Release Defines the Extended Pharmacokinetic Profiles of a Year-Long Cabotegravir

N. Gauram, J. M. McMillan, D. Kumar, A. N. Bade, Q. Pan, T. A. Kulkarni, W. Li, N. A. Smith, B. L. Dyavar Shetty, B. Sillman, A. Szlachetka, B. J. Edagwa, H. E. Gendelman, Y. Alnouti

This study demonstrates that a nanoformulated CAB prodrug (NM2CAB) maintains plasma levels above the inhibitory concentration for up to one year, with sustained drug retention in tissues and macrophages.

Nature Communications · Jun 8, 2021Peer-reviewedPharmacology & Toxicology